Skip to content
Novartis AG

Novartis AG technical analysis

NOVN.SWHealthcare Updated daily

Technical analysis of Novartis AG (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Novartis AG

Novartis AG is a pharmaceutical company that researches, develops, manufactures, and markets medicines internationally. Its product portfolio includes drugs for the treatment of cardiovascular, oncological, immunological, rheumatological, and other therapeutic conditions. The company is headquartered in Switzerland and distributes its medicines globally.

Description generated automatically from public sources; it may be inaccurate or out of date.

Novartis AG: latest session data

Closing values for September 4, 2026, computed on the last 12 months of prices.

Close129.58 CHF
Change−1.33%
RSI (14)57.4
MACD1.150
ADX15.2
Volatility (ATR)2.06%
Volume vs 20-avg118%
12-month high132.68 CHF
12-month low108.24 CHF

Moving averages

21 sessions

126.47 CHF

+2.46%

50 sessions

126.05 CHF

+2.80%

200 sessions

117.61 CHF

+10.18%

Session levels

s2

129.21

Support

s1

130.27

Support

pivot

131.47

Pivot

r1

132.53

Resistance

r2

133.73

Resistance

How to read it

In the September 4, 2026 session Novartis AG closed lower at 129.58 CHF, −1.33% versus the previous session.

The price sits above every moving average observed: +2.46% against the 21-session average, +2.80% against the 50 and +10.18% against the 200.

The 14-period RSI reads 57.4, in neutral territory.

MACD stands at 1.150 against a signal line at 0.652: the histogram is positive (+0.498).

ADX reads 15.2, indicating weak directionality.

Levels computed on the latest session place supports at 130.27 and 129.21 CHF and resistances at 132.53 and 133.73 CHF, around a pivot of 131.47.

The average daily range (ATR) is 2.673 CHF, or 2.06% of price.

Turnover was 2.6M shares, 118% of the 20-session average.

Over the last twelve months the price ranged between 108.24 and 132.68 CHF, and today stands −2.34% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Novartis AG

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the NOVN.SW analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Novartis AG

How is Novartis AG analysed technically?

Technical analysis of Novartis AG is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Novartis AG?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Novartis AG?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Novartis AG it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.